Predictive performance of physiologically based kinetic (PBK) models based on in-silico/in vitro-in vivo extrapolation (IS/IVIVE)

被引：0
|
作者：
Kalra, P. [1 ]
Zhou, H. [1 ]
Lawless, M. [1 ]
机构：
[1] Simulat Plus, Lancaster, PA USA
来源：
TOXICOLOGY LETTERS | 2023年 / 384卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P22-40
引用
收藏
页码：S259 / S260
页数：2
相关论文
共 50 条
  • [21] Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure
    Yeo, Karen Rowland
    Kenny, Jane R.
    Rostami-Hodjegan, Amin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (06) : 1311 - 1320
  • [22] Development and application of physiologically-based kinetic (PBK) models
    Madden, Judith
    Tan, Yu-Mei
    Blaauboer, Bas
    Paini, Alicia
    Computational Toxicology, 2020, 13
  • [23] Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
    Rostami-Hodjegan, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (01) : 50 - 61
  • [24] Analysis of Time-Dependent Pharmacokinetics Using In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
    Kim, Min-Chang
    Lee, Young-Joo
    PHARMACEUTICS, 2022, 14 (12)
  • [25] Development of physiologically based pharmacokinetic (PBPK) models for quantitative in vitro-in vivo extrapolations (QIVIVE)
    Punt, A.
    TOXICOLOGY LETTERS, 2022, 368 : S5 - S5
  • [26] Strategies to evaluate in vitro in silico physiologically based kinetic (PBK) models as essential tool in next generation (animal-free) risk evaluations
    Punt, A.
    Beekmann, K.
    Fabian, E.
    van Ravenzwaay, B.
    Carmichael, P. L.
    Sorrell, I.
    Moxon, T. E.
    TOXICOLOGY LETTERS, 2021, 350 : S46 - S46
  • [27] Refinement of in vitro to in vivo extrapolation (IVIVE) of potential endocrine disruptors based on in vitro dosimetry approaches
    Dimitrijevic, D.
    Fabian, E.
    Gomes, C.
    Funk-Weyer, D.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S67 - S67
  • [28] Species Extrapolation of Life-Stage Physiologically-Based Pharmacokinetic (PBPK) Models to Investigate the Developmental Toxicology of Ethanol Using In vitro to In vivo (IVIVE) Methods
    Martin, Sheppard A.
    McLanahan, Eva D.
    Bushnell, Philip J.
    Hunter, E. Sidney, III
    El-Masri, Hisham
    TOXICOLOGICAL SCIENCES, 2015, 143 (02) : 512 - 535
  • [29] Physiologically-Based Kinetic (PBK) Models and Applications In Read-Across
    Madden, J.
    Thompson, C.
    Webb, S.
    Penson, P.
    Tan, C.
    Paini, A.
    TOXICOLOGY LETTERS, 2023, 384 : S32 - S33
  • [30] CYP2B6 Pharmacogenetics-Based In Vitro-In Vivo Extrapolation of Efavirenz Clearance by Physiologically Based Pharmacokinetic Modeling
    Xu, Cong
    Quinney, Sara K.
    Guo, Yingying
    Hall, Stephen D.
    Li, Lang
    Desta, Zeruesenay
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2004 - 2011
12345